Dyslipidemia and serum cystatin C levels as biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus. - Dejenie TA; Abebe EC; Mengstie MA; Seid MA; Gebeyehu NA; Adella GA; Kassie GA; Gebrekidan AY; Gesese MM; Tegegne KD; Anley DT; Feleke SF; et al. (Frontiers in endocrinology, 2023)